Role of membrane cholesterol in leishmanial infection

Advances in Experimental Medicine and Biology

Volumn 749, Issue , 2012, Pages 201-213

  Chattopadhyay, Amitabha ^a   Jafurulla, Md ^a  

^a CENTRE FOR CELLULAR AND MOLECULAR BIOLOGY   (India)

Author keywords

[No Author keywords available]

Indexed keywords

AMPHOTERICIN B; CHOLESTEROL; CYCLODEXTRIN; NYSTATIN;

CONFERENCE PAPER; DEPLETION; DISEASE TRANSMISSION; DRUG EFFICACY; ENZYME INHIBITION; ENZYME STRUCTURE; HOST PATHOGEN INTERACTION; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS 1 INFECTION; LEISHMANIA; LEISHMANIASIS; MACROPHAGE; NONHUMAN; PRIORITY JOURNAL; TREATMENT RESPONSE;

ANIMALS; CHOLESTEROL; HOST-PATHOGEN INTERACTIONS; LEISHMANIASIS; MEMBRANE LIPIDS;

EID: 84863764386     PISSN: 00652598     EISSN: None     Source Type: Book Series    
DOI: 10.1007/978-1-4614-3381-1_14     Document Type: Conference Paper

References (68)

1. Alexander J, Satoskar AR, Russell DG (1999) Leishmania species: models of intracellular parasitism. J Cell Sci 112:2993-3002
2. Atger VM, de la Llera MM, Stoudt GW, Rodrigueza WV, Phillips MC, Rothblat GH (1997) Cyclodextrins as catalysts for the removal of cholesterol from macrophage foam cells. J Clin Invest 99:773-780
3. Bansal D, Bhatti HS, Sehgal R (2005) Role of cholesterol in parasitic infections. Lipids Health Dis 4:10
4. Berman J (2003) Current treatment approaches to leishmaniasis. Curr Opin Infect Dis 16: 397-401
5. Bolard J (1986) How do the polyene macrolide antibiotics affect the cellular membrane properties? Biochim Biophys Acta 864:257-304
6. Campbell SM, Crowe SM, Mak J (2001) Lipid rafts and HIV-1: from viral entry to assembly of progeny virions. J Clin Virol 22:217-227
7. Carter GC, Bernstone L, Sangani D, Bee JW, Harder T, James W (2009) HIV entry in macrophages is dependent on intact lipid rafts. Virology 386:192-202
8. Chakraborty D, Banerjee S, Sen A, Banerjee KK, Das P, Roy S (2005) Leishmania donovani affects antigen presentation of macrophage by disrupting lipid rafts. J Immunol 175: 3214-3224
9. Chappuis F, Sundar S, Hailu A, Ghalib H, Rijal S, Peeling RW, Alvar J, Boelaert M (2007) Visceral leishmaniasis: what are the needs for diagnosis, treatment and control ? Nat Rev Microbiol 5:873-882
10. Chaudhuri A, Chattopadhyay A (2011) Transbilayer organization of membrane cholesterol at low concentrations: implications in health and disease. Biochim Biophys Acta 1808:19-25
11. Clemente R, de Parseval A, Perez M, de la Torre JC (2009) Borna disease virus requires cholesterol in both cellular membrane and viral envelope for ef fi cient cell entry. J Virol 83:2655-2662
12. Cossart P, Roy CR (2010) Manipulation of host membrane machinery by bacterial pathogens. Curr Opin Cell Biol 22:547-554
13. Danthi P, Chow M (2004) Cholesterol removal by methyl- b -cyclodextrin inhibits poliovirus entry. J Virol 78:33-41
14. Davis ME, Brewster ME (2004) Cyclodextrin-based pharmaceutics: past, present and future. Nat Rev Drug Discov 3:1023-1035
15. de Kruijff B, Demel RA (1974) Polyene antibiotic-sterol interactions in membranes of Acholeplasma laidlawii cells and lecithin liposomes III. Molecular structure of the polyene antibiotic cholesterol complexes. Biochim Biophys Acta 339:57-70
16. Gatfield J, Pieters J (2000). Essential role for cholesterol in entry of Mycobacteria into macrophages. Science 288:1647-1650.
17. Gimpl G (2010) Cholesterol-protein interaction: methods and cholesterol reporter molecules. Subcell Biochem 51:1-45
18. Goluszko P, Nowicki B (2005) Membrane cholesterol: a crucial molecule affecting interactions of microbial pathogens with mammalian cells. Infect Immun 73:7791-7796
19. Handman E, Bullen DVR (2002) Interaction of Leishmania with the host macrophage. Trends Parasitol 18:332-334
20. Harrison T, Samuel BU, Akompong T, Hamm H, Mohandas N, Lomasney JW, Haldar K (2003) Erythrocyte G protein-coupled receptor signaling in malarial infection. Science 301:1734-1736
21. Härtel S, Diehl HA, Ojeda FS (1998) Methyl- b -cyclodextrins and liposomes as water-soluble carriers for cholesterol incorporation into membranes and its evaluation by a microenzymatic fl uorescence assay and membrane fluidity-sensitive dyes. Anal Biochem 258:277-284
22. Hawkes DJ, Mak J (2006) Lipid membrane; a novel target for viral and bacterial pathogens. Curr Drug Targets 7:1615-1621
23. Herwaldt BL (1999) Leishmaniasis. Lancet 354:1191-1199
24. Holz RW (1974) The effects of the polyene antibiotics nystatin and amphotericin B on thin lipid membranes. Ann NY Acad Sci 235:469-479
25. Jacobson K, Mouritsen OG, Anderson RGW (2007) Lipid rafts: at a crossroad between cell biology and physics. Nat Cell Biol 9:7-14
26. Khanna KV, Whaley KJ, Zeitlin L, Moench TR, Mehrazar K, Cone RA, Liao Z, Hildreth JE, Hoen TE, Shultz L, Markham RB (2002) Vaginal transmission of cell-associated HIV-1 in the mouse is blocked by a topical, membrane-modifying agent. J Clin Invest 109:205-211
27. Lauer S, VanWye J, Harrison T, McManus H, Samuel BU, Hiller NL, Mohandas N, Haldar K (2000) Vacuolar uptake of host components, and a role for cholesterol and sphingomyelin in malarial infection. EMBO J 19:3556-3564
28. Lee CJ, Lin HR, Liao CL, Lin YL (2008) Cholesterol effectively blocks entry of fl avivirus. J Virol 82:6470-6480
29. Liao Z, Cimakasky LM, Hampton R, Nguyen DH, Hildreth JE (2001) Lipid rafts and HIV pathogenesis: host membrane cholesterol is required for infection by HIV type 1. AIDS Res Hum Retrovir 17:1009-1019
30. Lingwood D, Simons K (2010) Lipid rafts as a membrane-organizing principle. Science 327:46-50
31. Liscum L, Underwood KW (1995) Intracellular cholesterol transport and compartmentation. J Biol Chem 270:15443-15446
32. Marty A, Finkelstein A (1975) Pores formed in lipid bilayer membranes by nystatin: differences in its one-sided and two-sided action. J Gen Physiol 65:515-526
33. Mouritsen OG (2010) The liquid-ordered state comes of age. Biochim Biophys Acta 1798:1286-1288
34. Mouritsen OG, Zuckermann MJ (2004) Whats so special about cholesterol? Lipids 39: 1101-1113
35. Mukherjee S, Max field FR (2004) Membrane domains. Annu Rev Cell Dev Biol 20:839-866
36. Olivier M, Gregory DJ, Forget G (2005) Subversion mechanisms by which Leishmania parasites can escape the host immune response: a signaling point of view. Clin Microbiol Rev 18: 293-305
37. Paila YD, Chattopadhyay A (2010) Membrane cholesterol in the function and organization of G-protein coupled receptors. Subcell Biochem 51:439-466
38. Paila YD, Murty MRVS, Vairamani M, Chattopadhyay A (2008) Signaling by the human serotonin 1A receptor is impaired in cellular model of Smith-Lemli-Opitz Syndrome. Biochim Biophys Acta 1778:1508-1516
39. Paila YD, Saha B, Chattopadhyay A (2010) Amphotericin B inhibits entry of Leishmania donovani into primary macrophages. Biochem Biophys Res Commun 399:429-433
40. Peyron P, Bordier C, NDiaye EN, Maridonneau-Parini I (2000) Nonopsonic phagocytosis of Mycobacterium kansasii by human neutrophils depends on cholesterol and is mediated by CR3 associated with glycosylphosphatidylinositol- anchored proteins. J Immunol 165:5186-5191
41. Pucadyil TJ, Chattopadhyay A (2006) Role of cholesterol in the function and organization of G-protein coupled receptors. Prog Lipid Res 45:295-333
42. Pucadyil TJ, Chattopadhyay A (2007) Cholesterol: a potential therapeutic target in Leishmania infection? Trends Parasitol 23:49-53
43. Pucadyil TJ, Shrivastava S, Chattopadhyay A (2004a) The sterol-binding antibiotic nystatin differentially modulates ligand binding of the bovine hippocampal serotonin 1A receptor. Biochem Biophys Res Commun 320:557-562
44. Pucadyil TJ, Tewary P, Madhubala R, Chattopadhyay A (2004b) Cholesterol is required for Leishmania donovani infection: implications in leishmaniasis. Mol Biochem Parasitol 133: 145-152
45. Pucadyil TJ, Shrivastava S, Chattopadhyay A (2005) Membrane cholesterol oxidation inhibits ligand binding function of hippocampal serotonin 1A receptors. Biochem Biophys Res Commun 331:422-427
46. Ren X, Glende J, Yin J, Schwegmann-Wessels C, Herrler G (2008) Importance of cholesterol for infection of cells by transmissible gastroenteritis virus. Virus Res 137:220-224
47. Riethmüller J, Riehle A, Grassmé H, Gulbins E (2006) Membrane rafts in host-pathogen interactions. Biochim Biophys Acta 1758:2139-2147
48. Rittig MG, Bogdan C (2000) Leishmania -host-cell interaction: complexities and alternative views. Parasitol Today 16:292-297
49. Rodríguez NE, Gaur U, Wilson ME (2006) Role of caveolae in Leishmania chagasi phagocytosis and intracellular survival in macrophages. Cell Microbiol 8:1106-1120
50. Rosenberger CM, Brumell JH, Finlay BB (2000) Microbial pathogenesis: lipid rafts as pathogen portals. Curr Biol 10:R823-R825
51. Rub A, Dey R, Jadhav M, Kamat R, Chakkaramakkil S, Majumdar S, Mukhopadhyaya R, Saha B (2009) Cholesterol depletion associated with Leishmania major infection alters macrophage CD40 signalosome composition and effector function. Nat Immunol 10:273-280
52. Sacks D, Noben-Trauth N (2002) The immunology of susceptibility and resistance to Leishmania major in mice. Nat Rev Immunol 2:845-858
53. Samuel BU, Mohandas N, Harrison T, McManus H, Rosse W, Reid M, Haldar K (2001) The role of cholesterol and glycosylphosphatidylinositol-anchored proteins of erythrocyte rafts in regulating raft protein content and malarial infection. J Biol Chem 276:29319-29329
54. Shin J-S, Abraham SN (2001) Caveolae as portals of entry for microbes. Microbes Infect 3: 755-761
55. Shin J-S, Gao Z, Abraham SN (2000) Involvement of cellular caveolae in bacterial entry into mast cells. Science 289:785-788
56. Shrivastava S, Pucadyil TJ, Paila YD, Ganguly S, Chattopadhyay A (2010) Chronic cholesterol depletion using statin impairs the function and dynamics of human serotonin 1A receptors. Biochemistry 49:5426-5435
57. Simons K, Ehehalt R (2002) Cholesterol, lipid rafts, and disease. J Clin Invest 110:597-603
58. Simons K, Ikonen E (2000) How cells handle cholesterol. Science 290:1721-1725
59. Simons K, Toomre D (2000) Lipid rafts and signal transduction. Nat Rev Mol Cell Biol 1:31-39
60. Tewary P, Veena K, Pucadyil TJ, Chattopadhyay A, Madhubala R (2006) The sterol-binding antibiotic nystatin inhibits entry of non-opsonized Leishmania donovani into macrophages. Biochem Biophys Res Commun 339:661-666
61. Tsamaloukas A, Szadkowska H, Slotte JP, Heerklotz H (2005) Interactions of cholesterol with lipid membranes and cyclodextrin characterized by calorimetry. Biophys J 89:1109-1119
62. van der Goot FG, Harder T (2001) Raft membrane domains: from a liquid-ordered membrane phase to a site of pathogen attack. Semin Immunol 13:89-97
63. van der Meer-Janssen YPM, van Galen J, Batenburg JJ, Helms JB (2010) Lipids in host-pathogen interactions: pathogens exploit the complexity of the host cell lipidome. Prog Lipid Res 49:1-26
64. Vieira FS, Corra G, Einicker-Lamas M, Coutinho-Silva R (2010) Host-cell lipid rafts: a safe door for micro-organisms? Biol Cell 102:391-407
65. Villalaín J (1996) Location of cholesterol in model membranes by magic-angle-sample-spinning NMR. Eur J Biochem 241:586-593
66. Wolday D, Berhe N, Akuffo H, Britton S (1999) Leishmania -HIV interaction: immunopathogenic mechanisms. Parasitol Today 15:182-187
67. World Health Organization Website http://www.who.int/leishmaniasis/en/
68. Zidovetzki R, Levitan I (2007) Use of cyclodextrins to manipulate plasma membrane cholesterol content: evidence, misconceptions and control strategies. Biochim Biophys Acta 1768: 1311-1324